APA (7th ed.) Citation

Lei, J. H., Lee, M., Miao, K., Huang, Z., Yao, Z., Zhang, A., . . . Xu, X. (2023). Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple‐Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy. Advanced Science, 10(36), 1. https://doi.org/10.1002/advs.202307935

Chicago Style (17th ed.) Citation

Lei, Josh Haipeng, et al. "Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple‐Negative Mammary Tumorigenesis That Is Sensitive to Immunotherapy." Advanced Science 10, no. 36 (2023): 1. https://doi.org/10.1002/advs.202307935.

MLA (9th ed.) Citation

Lei, Josh Haipeng, et al. "Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple‐Negative Mammary Tumorigenesis That Is Sensitive to Immunotherapy." Advanced Science, vol. 10, no. 36, 2023, p. 1, https://doi.org/10.1002/advs.202307935.